Armodios Hatzidakis, MD
Adult Reconstructive Orthopaedic Surgery · Denver, CONPI 1124031125
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (49.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Stryker accounts for 85.4% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $362,455, 3.0 times the $121,753 reported in 2019. Among adult reconstructive orthopaedic surgery clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 893 payments — averaging $1582.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1.2M
- Smith+Nephew$185K
- Shoulder Innovations, Inc.$8K
- Responsive Arthroscopy Inc$6K
- Synthes GmbH$3K
- Azurmeds, Inc.$2K
- plus $4K from 23 others
Across 79 payments — averaging $5976.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$230K
- Smith+Nephew$132K
- Arthrex$54K
- Lima USA, Inc.$34K
- Exactech, Inc.$23K
What the payments were for
- Royalty or licence$693,92349%
- Consulting fees$587,27442%
- Speaking & faculty fees$49,8234%
- Travel & lodging$63,8215%
- Food & beverage$17,5051%
- Education$1,2000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 602 | $1,206,547 |
| Smith+Nephew | 203 | $184,596 |
| Shoulder Innovations, Inc. | 6 | $8,000 |
| Responsive Arthroscopy Inc | 13 | $5,954 |
| Synthes GmbH | 5 | $2,934 |
| Azurmeds, Inc. | 2 | $1,655 |
| Gemini Mountain Medical, LLC | 4 | $1,276 |
| Integra Lifesciences Corporation | 20 | $1,205 |
| Radius Health, Inc. | 5 | $261 |
| Amgen | 4 | $179 |
| Medacta USA, Inc. | 1 | $150 |
| Johnson & Johnson(2 entities) | 5 | $134 |
| Arthrex | 1 | $112 |
| SPR Therapeutics, Inc | 1 | $99 |
| FX Shoulder Solutions, Inc | 2 | $48 |
| Davol Inc. | 1 | $47 |
| Solventum Corporation | 2 | $45 |
| Bioventus LLC | 3 | $44 |
| Vertex | 2 | $37 |
| Illuminoss Medical, Inc. | 1 | $36 |
| Avanos Medical | 2 | $31 |
| Anika Therapeutics, Inc. | 1 | $30 |
| Catalyst Orthoscience | 1 | $22 |
| Lima USA, Inc. | 1 | $22 |
| Exactech, Inc. | 1 | $19 |
| Osteoremedies, LLC | 1 | $19 |
| Kerecis Limited | 1 | $17 |
| Innovation Technologies Inc | 1 | $15 |
| Electronic Waveform Lab, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AEQUALIS PERFORM$691,295
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$166,548
- AEQUALIS$139,796
- AETOS Shoulder System$77,807
- SIMPLICITI$72,697
- AEQUALIS PERFORM REVERSED$61,555
- AEQUALIS ASCEND FLEX$57,042
- TORNIER PERFORM REVERSED GLENOID$48,980
- T2 ALPHA$41,320
- Bioinductive Implant with Arthroscopic Delivery System - Medium$37,329
- TORNIER PERFORM ANATOMIC AUGMENTED GLENOID$34,155
- TORNIER PERFORM REVERSED AUGMENTED GLENOID$33,499
- TWINFIX$25,111
- MAKO$16,275
- R&D UPPER EXT$16,250
- BIOLOGICS$12,914
- AXSOS$8,752
- REAL INTELLIGENCE$8,589
- InSet System$8,000
- T2$7,537
How this compares
$1,413,545 in reported general payments places this provider in the 95th percentile of 31 adult reconstructive orthopaedic surgery providers in Colorado.
See all adult reconstructive orthopaedic surgery providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 56 | $1,365 |
| Amoxicillin | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Denver
- Mark TuttleDenver$95K
- Jason JenningsDenver$45K
- Hailee ReistDenver$27K
- Brian LarkinDenver$5K
- Ryan CaufieldDenver$5K
- James HolmesDenver$328
- Sean GreyFort Collins$761K
- Kirk KindsfaterFort Collins$578K
- Derek JohnsonParker$181K
- Michael DaytonAurora$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.